Skip to content

Dr. Machteld Hofmans

Active
Private limited company (pre-2019)founded 2013active for 13 yearsNonnenstraat 16, 2800 Mechelen, BelgiumKBO/BCE: BE 0539.734.724
Summary

Dr. Machteld Hofmans has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €20,460 and a net result of €79,050. Equity has been stable since 2018 (±0% per year). Its solvency ranks better than 15% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 27-09-2013 Normal situation
Activity
General medical practice NACE 86210and 1 other
Establishment unit
2.222.958.502 2800 Mechelen, since 27-09-2013
Financial year end
31 December
Peppol
Reachable since 04-12-2025

Board and ownership

Board
  • Hofmans MachteldDirector · since 27-09-2013

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€104,229
▼ 14.9%
Turnover
≈ €190,000
estimated
Profit
€79,050
▼ 15.4%
Equity
€20,460
=
Total assets
€170,967
▼ 10.2%
Filed on 01-06-2026, 60 days before the deadline
Score breakdownraises riskEquity €20,460 (12.0% of total assets)lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.19, cash €126,790Size: total assets €170,967Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 40% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 37+1
equity 12.0% of total assets
Liquidity 54-1
short-term debt 83.5% · cash 74.2%
Profitability 100=
return on assets 46.2%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025highest value 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.19 (1.21 in 2024), below the usual 1.5. Short-term debt is 83.5% and cash 74.2% of total assets. 88% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 15% of them on solvency, 29% on liquidity, 80% on profitability and 37% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.19, cash €126,790
NBB · annual accounts
lowers risk · Size: total assets €170,967
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Equity €20,460 (12.0% of total assets)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 20678 sector peers (2025).
NBB · sector comparison
Position among 20678 sector peers
Solvency
better than 15%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-06-2026, 60 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
60 days early
2024
on the day
2023
5 days early
2022
5 days early
2021
9 days early
2020
23 days early
2019
14 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 17 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Lower solvency than 84% of companies in human healthsector median 63.0% · 20,678 companies 12.0% View
  • Positive: 8 profitable years in a rowprofit 2025: €79,050 8 years View
  • Positive: Filed on time since financial year 2019accounts within the deadline every year 7 years View

Comparable companies

These companies have the same main activity as Dr. Machteld Hofmans: general medical practice (NACE 86210). They are comparable in size and age: total assets between €135,000 and €183,000, founded between 2011 and 2016.

CompanyTotal assetsGross margin
Dr. Machteld Hofmans Mechelen€170,967€104,229
Cabinet médical Mélanie DELPERDANGE Bastogne€159,980€99,982
Dr. Annick Vermeersch, huisarts Ronse€147,648€105,803
MEDICA PRO - DR. IGNAT Drogenbos€180,824€98,435
Zeghli Sint-Jans-Molenbeek€182,919€106,138
DR DELAIVE JM Seraing€173,247€117,179
MUSICA MEDICA Mechelen€134,515€106,043
Full comparison

Key facts about Dr. Machteld Hofmans

What is the company number of Dr. Machteld Hofmans?
The company number of Dr. Machteld Hofmans is 0539.734.724. The VAT number is the same number with BE in front: BE 0539.734.724.
Where is Dr. Machteld Hofmans based?
The registered office is at Nonnenstraat 16, 2800 Mechelen.Company details
What does Dr. Machteld Hofmans do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Machteld Hofmans?
The legal form of Dr. Machteld Hofmans is Private limited company (pre-2019) (BVBA).
When was Dr. Machteld Hofmans founded?
Dr. Machteld Hofmans was founded on 27-09-2013.
Is Dr. Machteld Hofmans still active?
Yes, Dr. Machteld Hofmans is an active enterprise in the KBO register.
What is the turnover of Dr. Machteld Hofmans?
The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €104,229 and 30 comparable companies (NACE 86210). It probably lies between €150,000 and €230,000. In financial year 2018 turnover was €183,044.Financials
Is Dr. Machteld Hofmans profitable?
In financial year 2025, Dr. Machteld Hofmans made a profit of €79,050.
Where can I find the annual accounts of Dr. Machteld Hofmans?
Dr. Machteld Hofmans filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Machteld Hofmans due?
Dr. Machteld Hofmans must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.